Effect of Chronic Hematologic Malignancies on In-hospital Outcomes of Patients with ST-Segment Elevation Myocardial Infarction
In view of hemorrhagic and prothrombotic tendencies, ST-segment elevation myocardial infarction (STEMI) patients with chronic hematologic malignancies (CHM) are felt to be at a higher risk and hence denied standard reperfusion strategies. In-hospital outcomes of CHM patients presenting with STEMI are unclear. The Nationwide Inpatient Sample data files from 2003-2014 were used to extract adult patients who presented with a primary diagnosis of STEMI. Patients who had a diagnosis of CHM defined as chronic myelogenous leukemia, chronic lymphocytic leukemia, essential thrombocythemia, polycythemia vera, chronic monocytic leukemia, and multiple myeloma were identified.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Gaurav Patel, Neha Pancholy, Lisa Thomas, Anvit Rai, Akhil Kher, Christopher Peters, Amit Amin, Tejas Patel, Samir Pancholy Source Type: research
More News: Cancer & Oncology | Cardiology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukaemia | Heart | Heart Attack | Hematology | Hospitals | Leukemia | Myeloma